openPR Logo
Press release

Chronic Pruritus Market Analysis 2034: Statistics, Revenue, Clinical Trials, Prevalence, Medication, FDA, EMA, PDMA Approvals, and Companies by DelveInsight

06-26-2025 07:00 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Chronic Pruritus Market

Chronic Pruritus Market

(Albany, USA) DelveInsight's "Chronic Pruritus - Market Insight, Epidemiology, And Market Forecast - 2034′′ report offers an in-depth understanding of the Chronic Pruritus, historical and forecasted epidemiology as well as the Chronic Pruritus market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

The Chronic Pruritus Market is making significant strides, fueled by innovative treatment approaches and ongoing research advancements. DelveInsight's latest 7MM report delivers deep insights into key epidemiology trends and evolving market dynamics, shaping the future of chronic pruritus management.

Some of the key facts of the Chronic Pruritus Market Report:
• According to DelveInsight, the market for Chronic Pruritus in the 7MM is expected to witness notable growth during the study period from 2020 to 2034.
• The 12-month cumulative incidence of chronic pruritus in the general population may be as high as ~7%.
• KORSUVA (difelikefalin) is the first FDA-approved treatment for Chronic Kidney Disease-Associated Pruritus (CKD-aP).
• Other treatments for chronic pruritus include topical and systemic corticosteroids, antihistamines, immunomodulators, phototherapy, and other off-label medications.
• In Dec 2024, Galderma received U.S. FDA approval for Nemluvio® (Nemolizumab) for patients with moderate-to-severe atopic dermatitis.
• In Aug 2024, Galderma received U.S. FDA approval for Nemluvio® (Nemolizumab) for adult patients living with prurigo nodularis.
• In May 2024, Clexio reached the 50% enrollment milestone in the CLE-400 Phase II proof-of-concept study for subjects suffering from chronic pruritus associated with Notalgia Paresthetica.
• Emerging drugs in the chronic pruritus pipeline include Dupixent, CLE-400, and others.
• Key players in the chronic pruritus market include Sanofi, Keymed Biosciences, Bellus Health, Clexio Biosciences, and others.

To Know in detail about the Chronic Pruritus market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Chronic Pruritus Market Forecast - https://www.delveinsight.com/report-store/chronic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Pruritus Overview
Chronic pruritus (persistent itching) is a distressing condition lasting for more than six weeks, often associated with dermatological, neurological, systemic, or psychogenic disorders. Common causes include eczema, psoriasis, chronic kidney disease, diabetes, and nerve disorders. The persistent itch significantly impacts quality of life, leading to sleep disturbances, anxiety, and depression. Management depends on the underlying cause and may involve antihistamines, corticosteroids, immunomodulators, or targeted biologics.

Get a Free sample for the Chronic Pruritus Market Report: https://www.delveinsight.com/sample-request/chronic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Pruritus Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Chronic Pruritus Epidemiology Segmentation:
The Chronic Pruritus epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by:
• Prevalence-specific cases of chronic pruritus
• Disease-specific cases of chronic pruritus

Download the report to understand which factors are driving Chronic Pruritus epidemiology trends @ Chronic Pruritus Epidemiology Forecast - https://www.delveinsight.com/report-store/chronic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Chronic Pruritus Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Pruritus market or expected to be launched during the study period. The analysis covers the market uptake of chronic pruritus by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Chronic Pruritus Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Chronic Pruritus Market Strengths
• New insights into the neurological pathways of chronic itch are driving novel treatment developments.
• The growing recognition of chronic pruritus as a serious condition fuels demand for effective therapies

Chronic Pruritus Market Weaknesses
• Many current treatments provide only symptomatic relief without addressing the root cause.
• Patients with refractory pruritus often struggle to find effective and long-term solutions.

Request for sample report @ https://www.delveinsight.com/sample-request/chronic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Chronic Pruritus Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan
• Key Chronic Pruritus Therapies: Dupixent, CLE-400, and others.
• Key Chronic Pruritus Companies: Sanofi, Keymed Biosciences, Bellus Health, Clexio Biosciences, and others.
• Chronic Pruritus Therapeutic Assessment: Chronic Pruritus currently marketed and Chronic Pruritus emerging therapies
• Chronic Pruritus Market Dynamics: Chronic Pruritus market drivers and Chronic Pruritus market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Chronic Pruritus Unmet Needs, KOL's views, Analyst's views, Chronic Pruritus Market Access and Reimbursement

To learn more about the key players and advancements in the Chronic Pruritus Treatment Landscape, visit the Chronic Pruritus Market Analysis Report - https://www.delveinsight.com/sample-request/chronic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Chronic Pruritus Market Report Introduction
2. Executive Summary for Chronic Pruritus
3. SWOT analysis of Chronic Pruritus
4. Chronic Pruritus Patient Share (%) Overview at a Glance
5. Chronic Pruritus Market Overview at a Glance
6. Chronic Pruritus Disease Background and Overview
7. Chronic Pruritus Epidemiology and Patient Population
8. Country-Specific Patient Population of Chronic Pruritus
9. Chronic Pruritus Current Treatment and Medical Practices
10. Chronic Pruritus Unmet Needs
11. Chronic Pruritus Emerging Therapies
12. Chronic Pruritus Market Outlook
13. Country-Wise Chronic Pruritus Market Analysis (2020-2034)
14. Chronic Pruritus Market Access and Reimbursement of Therapies
15. Chronic Pruritus Market Drivers
16. Chronic Pruritus Market Barriers
17. Chronic Pruritus Appendix
18. Chronic Pruritus Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Neuroprosthetics Market: https://www.delveinsight.com/blog/neuroprosthetics-market-analysis
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Dysthymia Market: https://www.delveinsight.com/report-store/persistent-depressive-disorder-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/ats-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Pruritus Market Analysis 2034: Statistics, Revenue, Clinical Trials, Prevalence, Medication, FDA, EMA, PDMA Approvals, and Companies by DelveInsight here

News-ID: 4083962 • Views:

More Releases from DelveInsight Business Research

Neuroendocrine Tumors Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight
Neuroendocrine Tumors Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication …
(Albany, USA) DelveInsight's, "Neuroendocrine tumors Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Neuroendocrine tumors pipeline landscape. It covers the Neuroendocrine Tumors pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Neuroendocrine Tumors pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs
Pulmonary Sarcoidosis Market Insight 2032: Clinical Trials, Revenue, Statistics, EMA, PDMA, FDA Approvals, Medication, Therapies, Prevalence, Companies by DelveInsight
Pulmonary Sarcoidosis Market Insight 2032: Clinical Trials, Revenue, Statistics, …
(Albany, USA) DelveInsight's "Pulmonary Sarcoidosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Pulmonary Sarcoidosis, historical and forecasted epidemiology as well as the Pulmonary Sarcoidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Pulmonary Sarcoidosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pulmonary
Carpal Tunnel Syndrome Market Insight 2032: Revenue, Statistics, EMA, PDMA, FDA Approvals, Medication, Clinical Trials, Therapies, Prevalence, Companies by DelveInsight
Carpal Tunnel Syndrome Market Insight 2032: Revenue, Statistics, EMA, PDMA, FDA …
(Albany, USA) DelveInsight's "Carpal Tunnel Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Carpal Tunnel Syndrome, historical and forecasted epidemiology as well as the Carpal Tunnel Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Carpal Tunnel Syndrome market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore,
Parkinson's Disease Market Insight 2034: Revenue, Statistics, EMA, PDMA, FDA Approvals, Medication, Clinical Trials, Therapies, Prevalence, Companies by DelveInsight
Parkinson's Disease Market Insight 2034: Revenue, Statistics, EMA, PDMA, FDA App …
(Albany, USA) DelveInsight's "Parkinson's Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Parkinson's Disease, historical and forecasted epidemiology as well as the Parkinson's Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The Parkinson's Disease market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to

All 5 Releases


More Releases for Chronic

Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Reviewed, …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017”, provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney Disease (Chronic Renal Failure). Report includes an overview of trial numbers and
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market Res …
Latest industry research report on: Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Kidney Disease (Chronic Renal Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Kidney
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
11-10-2016 | Health & Medicine
MRR.biz
Global Chronic, Acute, And Neuropathic Pain Market: Opioids To Remain Most Value …
The research report, titled “Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes,” analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain. According to this 68-page study, the worldwide market for chronic, acute, and neuropathic pain has been observing a significant
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently